EUVIMEDΑνακαλύψτε το EUVIMED
Crossref

NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy

Hai Bai, Wanqing Xu, Guozheng Wei, Yue Cao, Mingming Wang

Applied Biochemistry and Biotechnology · 2026-12 · 198 (12) · 10685-10710

DOI: 10.1007/s12010-026-05931-3 ↗

At a glance

Journal article in Applied Biochemistry and Biotechnology, published online on 2026-09-23. Written by Hai Bai and 4 co-authors. Institution: Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China. Major MEDLINE topics: Immunotherapy, Neoplasms, Biomarkers, Tumor, Nuclear Proteins. 41 references. Funded by: National Natural Science Foundation of China.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

BACKGROUND: Nucleolar complex associated 4 homolog (NOC4L) is implicated in the pathogenesis of various diseases and has been reported to play a role in tumorigenesis. However, its diagnostic and prognostic significance across diverse cancer types remains underexplored. METHODS: This study employed bioinformatics methodologies to analyze NOC4L expression across diverse cancers using public databases, including The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) project. Comprehensive analyses, including survival analysis, receiver operating characteristic (ROC) curves, and functional enrichment studies, were performed to assess the clinical significance of NOC4L expression. RESULTS: NOC4L mRNA expression was significantly elevated in multiple cancers, with notable upregulation observed in bladder (BLCA), breast (BRCA), and colon (COAD) cancers, showing significant differences when compared to adjacent normal tissues. Kaplan-Meier survival analysis indicated that NOC4L expression is associated with overall survival in 20 cancer types, suggesting its potential as an independent prognostic marker. Additionally, variation in NOC4L expression among different immune subtypes points to its role in modulating the tumor immune microenvironment. Protein-protein interaction network analysis identified key proteins associated with cancer prognosis. Gene Ontology and KEGG pathway analyses revealed that NOC4L-related genes are involved in critical cancer-related pathways, including ribosome biogenesis, cell cycle regulation, and DNA damage response. CONCLUSIONS: NOC4L shows promise as a dual-action target, functioning both as a prognostic biomarker and as a potential immunotherapeutic target. These insights provide a foundation for future research into its potential therapeutic applications.

Subjects

MeSH terms (MEDLINE)

ImmunotherapyNeoplasmsBiomarkers, TumorNuclear ProteinsHumansPrognosisGene Expression Regulation, Neoplastic

Author keywords

BiomarkersImmune MicroenvironmentImmunotherapyNOC4LPrognostic Marker

Substances

Biomarkers, TumorNuclear Proteins

Authors and institutions

  • Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China.
  • Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China.
  • Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China.
  • Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China. wmm@xzhmu.edu.cn.
  • Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.
  • National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.

Funding

  • National Natural Science Foundation of China

Cite

APA

Bai, H., Xu, W., Wei, G., Cao, Y., & Wang, M. (2026). NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology, 198(12), 10685-10710. https://doi.org/10.1007/s12010-026-05931-3

Vancouver

Bai H, Xu W, Wei G, Cao Y, Wang M. NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology. 2026;198(12):10685-10710. doi:10.1007/s12010-026-05931-3

BibTeX
@article{Bai2026,
  author = {Bai, Hai and Xu, Wanqing and Wei, Guozheng and Cao, Yue and Wang, Mingming},
  title = {NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  volume = {198},
  number = {12},
  pages = {10685--10710},
  doi = {10.1007/s12010-026-05931-3}
}
Start for free →